Breaking News
0
Ad-Free Version. Subscribe now to follow markets, faster and distraction-free. More details
Close

Nabriva Therapeutics AG (NBRV)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Nabriva Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.790 +0.040    +2.29%
05/03 - Closed. Currency in USD ( Disclaimer )
Pre Market
1.700
-0.090
-5.028%
10:06:22 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  IE00BL53QQ85 
CUSIP:  00BYQMW23
  • Volume: 3,482,013
  • Bid/Ask: 1.700 / 1.730
  • Day's Range: 1.520 - 1.840
Nabriva Therapeutics 1.790 +0.040 +2.29%
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close1.79
Day's Range1.52 - 1.84
Revenue2.9M
Open1.75
52 wk Range1.52 - 14.7
EPS - 7.59
Volume3,482,013
Market Cap63.34M
Dividend (Yield)N/A (N/A)
Average Volume (3m)1,619,756
P/E RatioN/A
Beta1.97
1-Year Change - 88.3%
Shares Outstanding15,077,568
Next Earnings DateMar 11, 2021
What is your sentiment on Nabriva Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Nabriva Therapeutics AG News


Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Buy Buy Sell Strong Sell Sell
Technical Indicators Strong Buy Strong Buy BUY Strong Sell Sell
Summary Strong Buy Strong Buy Neutral Strong Sell Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Bullish Engulfing 5H Current
Harami Cross 1D Current
Completed Patterns
Advance Block Bearish 1H 1 Mar 05, 2021 20:00
Falling Three Methods 1W 2 Feb 21, 2021
Doji Star Bearish 30 2 Mar 05, 2021 20:30

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Zenith Bank 25.20 25.20 25.20 -0.10 -0.40% 796.51K 10:10:00  
  Guaranty Trust Bank 31.50 31.50 31.50 +0.50 +1.61% 0.93K 10:00:00  
  UBA 8.00 8.00 8.00 +0.05 +0.63% 0.70K 10:00:00  
  FBN Holdings 7.10 7.10 7.10 0.00 0.00% 53.77K 10:00:00  
  MTN Nigeria 167.90 167.90 167.90 -2.10 -1.24% 7.01K 10:06:00  
  United Capital 4.650 4.620 4.610 -0.410 -8.17% 1.04M 10:10:00  
  Access Bank 7.80 7.80 7.80 0.00 0.00% 35.92K 10:07:00  
  Jaiz Bank 0.68 0.68 0.68 +0.01 +1.49% 0.12K 10:00:00  
  Conoil 18.90 18.90 18.90 0.00 0.00% 1.20K 10:00:00  
  Fidson 4.650 4.650 4.650 0.000 0.00% 4.50K 10:00:00  

Nabriva Therapeutics AG Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

162

Equity Type

ADR

Nabriva Therapeutics plc is a biopharmaceutical company engaged in the commercialization and development of anti-infective agents to treat serious infections. The Company’s product XENLETA (lefamulin), is a semi-synthetic pleuromutilin antibiotic for systematic administration in humans. It inhibits the synthesis of bacterial protein, which is required for bacteria to grow by binding with high affinity, high specificity and at molecular targets that are different than other antibiotic classes. The Company is also developing CONTEPO (fosfomycin) for injection, a potential first-in-class epoxide antibiotic for complicated urinary tract infections (cUTI), including acute pyelonephritis.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NBRV Comments

Write your thoughts about Nabriva Therapeutics AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email